Header Logo

Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?

Roch AM, Kim RC, Nguyen TK, House MG, Zyromski NJ, Nakeeb A, Schmidt CM, Ceppa EP. Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening? J Surg Oncol. 2023 Aug; 128(2):289-294.

View in: PubMed